Almirall acquires US skin medications from Allergan for $550m
Spanish pharma company Almirall has completed its $550 million acquisition of five skin medications from Allergan’s Medical Dermatology unit in
Continue reading
Tag: Tazorac
Latest Pharma Industry News
-
Novartis to acquire US biopharma company Endocyte for $2.1bn
-
Quotient Sciences opens formulation, manufacturing facility in US near Philadelphia
-
BMS’ Opdivo flops in CheckMate -331 trial in small cell lung cancer
-
Synspira’s cystic fibrosis treatment PAAG15A gets FDA orphan designation
-
MaaT Pharma doses first patient in HERACLES phase 2 trial of MaaT013
-
BMS, Compugen to trial COM701 Opdivo combo in advanced solid tumors
-
Eyevance bags global rights of ophthalmic drug Nexagon from OcuNexus
-
GNI Group to stop patient enrolment in F351 phase 2 liver fibrosis trial
-
FDA approves new dosing option for Amgen blood cancer drug Kyprolis
-
Five Prime, Zai Lab initiate phase 3 trial of bemarituzumab chemo combo
Business News Today
- Graham Contracting set to bag WSDOT contract for SR 520 Montlake Project
- GE bags contract for turbine islands for $30bn El Dabaa nuclear power plant
- Walmart snaps up online lingerie retailer Bare Necessities
- US online mattress company Nectar Sleep forays into UK market
- Online groceries delivery service Instacart to build new tech hub in Canada
- innogy breaks ground on 349MW Limondale solar plant in New South Wales
- Wartsila breaks ground on Hamina LNG terminal in Finland
- Vestas to supply 356MW turbines for MidAmerican Energy 2GW Wind XI project
- ADB sanctions $300m loan to upgrade East-West Highway in Georgia
- Physician’s Choice launches NatREM natural sleep aid
